NEGOZIO

RET Breakapart

Clinic Significance:
1.This occurs in 1-2% of patients with non-small cell lung adenocarcinoma
2.The expression was lower in normal lung tissue, and the gene rearrangement activated the kinase active domain of RET, and the expression was higher in lung cancer samples.
Three targeted drugs, Vandetanib, Sorafenib and Sunitinib, inhibit the activity of multiple receptor tyrosine kinases including RET, and to kill cells carrying RET fusion gene.

Contrast

RET Normal

RET Breakapart

Maggiori informazioni

Probe Description: RET

Cat.No.: CF1019

Specification: 10 tests/box, 20 tests/box

Prodotto correlato

Mettiti in contatto

Se hai una richiesta o qualche feedback per noi, compila il modulo sottostante per contattare il nostro team.

superiore